IGUCHI KIMI 4
4 · Sage Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
IGUCHI KIMI
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-01-02$1.36/sh+1,642$2,233→ 70,429 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-01-02−1,642→ 0 totalExercise: $1.36Exp: 2024-01-22→ Common Stock (1,642 underlying)
Footnotes (1)
- [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.